Previous close | 12,170.00 |
Open | 12,114.00 |
Bid | 12,142.00 x 0 |
Ask | 12,144.00 x 0 |
Day's range | 12,048.00 - 12,258.00 |
52-week range | 9,461.00 - 12,488.00 |
Volume | |
Avg. volume | 2,955,850 |
Market cap | 188.447B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 37.52 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (1.87%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript April 25, 2024 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.03 EPS, expectations were $1.22. AstraZeneca PLC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning to those joining […]
European pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of Oxford, is facing a class action lawsuit alleging its vaccine caused death and serious injury in numerous cases. Lawyers representing the plaintiffs argue that the vaccine resulted in side effects for a small number of families, including brain injuries and fatalities. AstraZeneca, while contesting the claims, has acknowledged in court documents that its vaccine can, in rare instances, cause Thro
(Reuters) -Britain's FTSE 100 extended its record rally for the fifth straight session on Monday, helped by positive corporate updates, while a stronger pound boosted midcaps. The mid-cap FTSE 250 advanced 1.3%, after touching highest levels in over thirteen months, and taking support from a rise in pound as the currency reached its highest in around two weeks against the dollar. FTSE 100 stocks move in an inverse relationship to the currency, earning their revenues in dollars while reporting profits in sterling, but they were supported by positive company news.